Today's Daily Dose brings you news about Ardelyx' PHREEDOM trial results; narcolepsy trial results of Axsome; TRANSCEND trial results of Protagonist Therapeutics and FDA approval of Roche's (RHHBY.OB) Tecentriq for yet another indication.
from RTT - Biotech https://ift.tt/2ONy4jw
via IFTTT
No comments:
Post a Comment